By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

IR BioSciences Holdings, Inc. 

8655 Via de Ventura Boulevard, Suite E-155

Scottsdale  Arizona  85258  U.S.A.
Phone: 480-922-3926 Or 866-922-3926
Fax: 480-922-4781


SEARCH JOBS


Industry
Biotechnology






Company News
IR BioSciences Holdings, Inc. (IRBO) Closes New $5 Million Funding Round 8/11/2008 6:39:23 AM
IR BioSciences Holdings, Inc. (IRBO) Appoints Former VaxGen, Inc. (VXGN) Chief Executive Lance K. Gordon Ph.D. to Its Board of Directors 5/15/2007 10:26:22 AM
IR BioSciences Holdings, Inc. (IRBO) Announces Promising Data from Study of Its Compound Homspera 5/7/2007 2:56:07 PM
IR BioSciences Holdings, Inc. (IRBO) Appoints Dr. Robert Hariri to Its Board of Directors 4/25/2007 2:03:56 PM
IR BioSciences Holdings, Inc. (IRBO) Appoints Celgene Corporation (CELG) Executive Dr. Robert Hariri to Its Board of Directors 4/25/2007 10:32:25 AM
IR BioSciences Holdings, Inc. (IRBO) Responds to the Recently Cancelled Acute Radiation Syndrome (ARS) RFP by DHHS 3/14/2007 2:31:24 PM
IR BioSciences Holdings, Inc. (IRBO) Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal Irradiation 3/8/2007 1:20:09 PM
IR BioSciences Holdings, Inc. (IRBO) to Collaborate with Leading Clinical Services Company to Evaluate Radilex(TM) in Low-Level Radiation Exposure 2/26/2007 1:09:49 PM
ImmuneRegen BioSciences, Inc. (IRBO) And Oak Ridge National Laboratory Announce Initial Results From Radilex(TM) Testing 6/1/2006 10:41:00 AM
ImmuneRegen BioSciences, Inc. (IRBO) Plans Response To Upcoming Department of Health and Human Services RFP For Advanced Development Of New Antiviral Agents For Influenza 5/31/2006 12:43:27 PM
12
//-->